Wednesday, December 13, 2017 10:13:23 AM
VANCOUVER, British Columbia, Dec. 13, 2017 (GLOBE NEWSWIRE) -- Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce Be Tru Organics™ has commenced the process of distributing product to Erewhon Natural Foods, a premier supermarket chain in California.
“We are always looking for new ways to expand our company’s reach and further diversify our product offerings,” said Marcos Agramont, CEO of Isodiol. “We closed the 100% acquisition of Be Tru last week, and in this short amount of time, we have already seen strong results from this partnership. This partnership will continue to open additional revenue streams, and enable Isodiol to penetrate the mainstream market and provide consumers with natural, high-quality, health and wellness products.”
Since the late 1960s, Erewhon has been committed to providing foods and products that change the lives of consumers. Erewhon sets the standard for the highest quality ingredients possible and endlessly works towards providing their consumers with the best foods and products the earth can offer.
“Be Tru is very pleased to share this update and we expect many more opportunities to present themselves in the coming months,” said Keith Gordon, CEO of Be Tru Organics. “As we move along in our partnership with Isodiol, we will begin to include their products in our distribution.”
For more information on Isodiol, please visit www.isodiol.com
For more information on Be Tru Organics™, please visit www.betruorganics.com
About Isodiol International Inc.
Isodiol International Inc. is the market leader in pharmaceutical grade phytochemical compounds and the industry leader in the manufacturing and development of phytoceutical consumer products.
Isodiol is the pioneer of many firsts for the cannabis industry including commercialization of 99%+ pure, bioactive pharmaceutical grade cannabinoids, micro-encapsulations, and nanotechnology for the highest quality consumable and topical skin care products.
Isodiol's growth strategy includes the development of over-the-counter and pharmaceutical drugs, expanding its phytoceutical portfolio and will aggressively continue international expansion into Latin America, Asia and Europe.
Join Us On Facebook: https://www.facebook.com/isodiol/
Twitter:@isodiol
ON BEHALF OF THE BOARD
Marcos Agramont,CEO & Director
INVESTOR RELATIONS:
Ir@isodiol.com
www.isodiol.com
MEDIA CONTACT:
Carrie Booze
North 6th Agency
212-334-9753 ext.142
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM